, , , , , , , , , ,

In my presentation I highlight the implications on inovation due to biosafety regulatory costs and time delays especially for developing countries organizatiosn working on public goods. You can find more information on the conference GMCC-13, the sixth International Conference on Coexistence between Genetically Modified (GM) and non-GM based Agricultural Supply Chains here:GMCC 13 click here